SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-01-500252
Filing Date
2001-03-07
Accepted
2001-03-07 00:00:00
Documents
10
Period of Report
2000-12-05
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 INTERLEUKIN GENETICS INC. b38587ige8-k.txt 8-K 4685
2 PURCHASE AGREEMENT 12/5/00 b38587igex10-1.txt EX-10.1 67264
3 REGISTRATION RIGHTS AGREEMENT b38587igex10-2.txt EX-10.2 40111
4 PURCHASE AGREEMENT 1/26/01 b38587igex10-3.txt EX-10.3 66652
5 REGISTRATION RIGHTS AGREEMENT 1/26/01 b38587igex10-4.txt EX-10.4 40877
6 CONSENT, WAIVER, AND AMENDMENT AGREEMENT b38587igex10-5.txt EX-10.5 11127
7 WARRANT TO PURCHASE 330,000 SHARES b38587igex10-6.txt EX-10.6 22719
8 WARRANT TO PURCHASE 160,000 SHARES b38587igex10-7.txt EX-10.7 22719
9 WARRANT TO PURCHASE 110,000 SHARES b38587igex10-8.txt EX-10.8 22850
10 WARRANT TO PURCHASE 264,407 SHARES b38587igex10-9.txt EX-10.9 22979
  Complete submission text file 0000950135-01-500252.txt   324869
Mailing Address 100 NE LOOP 410 STE 820 SAN ANTONIO TX 78216
Business Address 100 NE LOOP 410 STE 820 SAN ANTONIO TX 78216-4749 2103496400
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23413 | Film No.: 1562472
SIC: 8071 Services-Medical Laboratories